Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Pharmacy by Medi-Market Group - Zemst from Evere, company number BE0670966420, closed financial year 2025 with a result of € 20,938 after tax. For that financial year Pharmacy by Medi-Market Group - Zemst recorded a gross margin of € 71,424 and equity of € -111,208. Compared with financial year 2024, the result moved from € 19,205 to € 20,938. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ -111,208
▲ € 20,938 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 20,938
▲ 9% vs 2024
Profit after tax over the fiscal year.
€ 0
▼ 100% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -173,208.
People and assets in 2025
€ 11,456
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 62,000
▲ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 49,946 | € 77,821 | € 75,770 | € 71,424 | ▼ 6% |
| Profit after taxes | € 2,696 | € 17,038 | € 19,205 | € 20,938 | ▲ 9% |
| Equity | € -168,389 | € -151,351 | € -132,146 | € -111,208 | ▲ € 20,938 |
| Total debts | € 629,651 | € 663,787 | € 696,077 | € 720,932 | ▲ 4% |
| Cash | € 1,359 | € 2,204 | € 8,940 | € 0 | ▼ 100% |
| Retained profit | € -230,389 | € -213,351 | € -194,146 | € -173,208 | ▲ € 20,938 |
| Balance sheet total | € 461,261 | € 512,435 | € 563,931 | € 609,724 | ▲ 8% |
Key figures of Pharmacy by Medi-Market Group - Zemst, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharmacy by Medi-Market Group - Zemst?
What happened at Pharmacy by Medi-Market Group - Zemst in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 20,938 (▲ 9% vs 2024). Source: NBB ↗
- New establishment in Evere. KBO
- Medi-Market Group SA became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 2,696 profit in 2022 to € 20,938 profit in 2025.
Best year ever: 2025, with € 20,938 profit.
A new publication or filing at Pharmacy by Medi-Market Group - Zemst? We notify you, reason included.
Follow Pharmacy by Medi-Market Group - ZemstDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharmacy by Medi-Market Group - Zemst is Medi-Market Group SA. The shares are held by PharmaClic Assets (100%).
Directors
According to the 2025 annual accounts
Director · represented by Antoine Cédric
Owns 100% via PharmaClic Assets
Also active at: Pharmacie by Medi-Market Group – Waterloo Bix, Parapharmacity, Medi-Market Mons Grand Pré, MEDI-MARKET Parapharmacies, Pharmacie by Medi-Market Group - Gosselies, Pharmacies by Medi-Market Group, Pharmacie by Medi-Market Group - Bruxelles Docks, Pharmacie by Medi-Market Group - Schoten +7 more
since 2020
Shareholders
PharmaClic Assets · holding of Medi-Market Group SA
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Cicerolaan 7
1140 Evere
Cicerolaan 7 box A
1140 Evere
Active since 1 January 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →Pharmacie by Medi-Market Group – Waterloo Bix same network
€ 77,722 gross margin · 2025
Parapharmacity same network
€ 20,926 gross margin · 2025
Medi-Market Mons Grand Pré same network
€ 9,529 gross margin · 2025
MEDI-MARKET Parapharmacies same network
€ 326.6 million revenue · 2025
Pharmacie by Medi-Market Group - Gosselies same network
€ 184,051 gross margin · 2025
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0670.966.420
- VAT number
- BE 0670.966.420
- Registered office
- Cicerolaan 7, 1140 Evere
- Names & denominations
- Pharmacy by Medi-Market Group - Zemst · Pharmacy by MMG - Zemst · Pharmacie by Medi-Market Group - Zemst
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 February 2017
- Peppol
- Active · Active since 2 Jan 2026
- Activities · NACE
Overige zakelijke dienstverlening, neg